AnGes To Withdraw, Refile HGF Gene Therapy In Japan

 
• By Lisa Takagi
AnGes will once pull out Collategen from the Japanese market, and then refile for approval.
AnGes will pull Collategene from Japanese market then refile for approval • Source: Shutterstock

More from Japan

More from Asia